// App-Quantinova.ai

TCT-746 : Outcomes by Total Stent Length in ACS PCI with Second Generation Drug-Eluting Stents: Results from the PROMETHEUS Study

Researchers

Presenter

  • Asha Mahajan

Principal Investigators

  • Samantha Sartori

  • Usman Baber

  • Birgit Vogel

  • Sabato Sorrentino

  • Clayton Snyder

  • Annapoorna Kini

  • Sunil Rao

  • Samir Kapadia

  • Timothy Henry

  • Mark Effron

  • William Weintraub

  • Sandra Weiss

  • Craig Strauss

  • Anthony DeFranco

  • Catalin Toma

  • Stuart Keller

  • Brian Baker

  • Stuart Pocock

  • Roxana Mehran

Medical Centers

  • Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Hospital, New York, New York, United States

  • ACS, Grafton, Wisconsin, United States

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Duke University Medical Center, Durham, North Carolina, United States

  • Ochsner Medical Center, New Orleans, Louisiana, United States

  • Heart and Vascular Institute, Cleveland, Ohio, United States

  • Heart and Vascular Institute, UPMC Presbyterian, Pittsburgh, Pennsylvania, United States

  • Cedars Sinai Medical Center, Los Angeles, California, United States

  • Christiana Care Health Services, Newark, Delaware, United States

  • Mount Sinai Health System, New York, New York, United States

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

  • Minneapolis Heart Institute, Minneapolis, Minnesota, United States

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Prasugrel

Outcome

  • N/A

Study Design

  • Observational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved